Skip to main content

Applying AI-powered digital pathology for personalized drug response prediction

31 Oct 2024
Drug Response Prediction
  1. How can digital pathology and AI be utilized for patient selection and pharmacodynamic biomarker discovery, development, and deployment?
  2. What are the relative benefits of H&E, multiplex IF, and IHC-based digital pathology biomarkers throughout the stages of drug development and for clinical implementation?
  3. What are the applications, opportunities and challenges of AI-powered digital pathology to support drug development?
  4. Where is the AI-digital pathology field headed next?
Industry Experts
Laura Dillon, VP Translational Medicine & Bioinformatics - Incendia Therapeutics